Sun Pharma eyes $4 billion loan for Organon buy, five banks likely to anchor refinancing - The Economic Times
Sun Pharmaceutical Industries is gearing up to secure a substantial $4 billion syndicated loan aimed at refining its financial structure. This initiative is focused on refinancing a portion of the bridge financing used for its acquisition of Organon & Co. The company has recruited five lead arrangers to finalize the loan's terms.